Edition:
United States

People: Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

3,186.45INR
5:12am EST
Change (% chg)

Rs-13.75 (-0.43%)
Prev Close
Rs3,200.20
Open
Rs3,191.00
Day's High
Rs3,215.00
Day's Low
Rs3,170.00
Volume
10,810
Avg. Vol
24,551
52-wk High
Rs3,689.00
52-wk Low
Rs2,750.00

Reddy, Satish 

Mr. Satish K. Reddy is Chairman of the Board of Dr. Reddy's Laboratories Ltd since May 2014. His association with Dr Reddy’s began in 1993 when he joined Dr Reddy’s Laboratories as Executive Director. Satish led the company’s transition from a maker of active pharmaceutical ingredients into an integrated player making formulations as well. Under his leadership, the company established a strong footing in India’s formulations market, and expanded into Russia and the CIS countries among other emerging markets. In 1997 he became Managing Director and in 2013 he was appointed Vice Chairman and Managing Director. In May 2014 the Dr Reddy’s Board appointed him Chairman. Satish plays a key role in shaping government policy on crucial issues concerning the pharmaceutical sector and the economy. As a member of key industry organisations he has contributed to policy on India’s Patent law, pharmaceutical pricing, and key amendments to the Drugs & Cosmetics Act, among other issues critical to the pharmaceutical sector and the economy. He has been a member of the Drugs Technical Advisory Board of India, the highest policy making body under the Drugs and Cosmetics Act in India (2005 and 2011), the chairman of the Andhra Pradesh Chapter of the Confederation of Indian Industries (CII) in the financial year 2003-2004, and the National Council on Pharmaceuticals. Currently, he is President of the Indian Pharmaceutical Alliance, a premier industry association of leading research-based Indian companies. Satish was identified as a “Young Global Leader for 2007” by the World Economic Forum, and was awarded the “IBLA - India Corporate Citizen of the Year" by CNBC in 2005 for his contributions to Corporate Social Responsibility. He holds a degree in Chemical Engineering from Osmania University, India, and an M.S. in Medicinal Chemistry from Purdue University, USA, where he received the 2009 Distinguished Alumnus Award from the School of Pharmacy and Pharmaceutical Sciences.

Basic Compensation

Total Annual Compensation, INR 107,650
Restricted Stock Awards, INR --
Long-Term Incentive Plans, INR --
All Other, INR 6,989
Fiscal Year Total, INR 114,639

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Satish Reddy

114,639

G. Prasad

109,464,000

Saumen Chakraborty

15,000,000

Sripada Chandrasekhar

--

Abhijit Mukherjee

14,600,000

Amit Biswas

--
As Of  30 Mar 2014